Pre-order Enquiry
Request Free Sample
Global Pharma 4.0 Market 2022 by Company, Regions, Type and Application, Forecast to 2028
SKU ID : GIR-21184053 | Publishing Date : 01-Jul-2022 | No. of pages : 113
Detailed TOC of Global Pharma 4.0 Market 2022 by Company, Regions, Type and Application, Forecast to 2028
1 Market Overview1.1 Product Overview and Scope of Pharma 4.0
1.2 Classification of Pharma 4.0 by Type
1.2.1 Overview: Global Pharma 4.0 Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Pharma 4.0 Revenue Market Share by Type in 2021
1.2.3 Cloud
1.2.4 On-premise
1.3 Global Pharma 4.0 Market by Application
1.3.1 Overview: Global Pharma 4.0 Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pharmaceutical Industry
1.3.3 IoT Industry
1.3.4 Medical Equipment Industry
1.3.5 Others
1.4 Global Pharma 4.0 Market Size & Forecast
1.5 Global Pharma 4.0 Market Size and Forecast by Region
1.5.1 Global Pharma 4.0 Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Pharma 4.0 Market Size by Region, (2017-2022)
1.5.3 North America Pharma 4.0 Market Size and Prospect (2017-2028)
1.5.4 Europe Pharma 4.0 Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Pharma 4.0 Market Size and Prospect (2017-2028)
1.5.6 South America Pharma 4.0 Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Pharma 4.0 Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharma 4.0 Market Drivers
1.6.2 Pharma 4.0 Market Restraints
1.6.3 Pharma 4.0 Trends Analysis
2 Company Profiles
2.1 Pfizer Inc
2.1.1 Pfizer Inc Details
2.1.2 Pfizer Inc Major Business
2.1.3 Pfizer Inc Pharma 4.0 Product and Solutions
2.1.4 Pfizer Inc Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Pfizer Inc Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Pharma 4.0 Product and Solutions
2.2.4 Abbott Laboratories Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 GE Healthcare
2.3.1 GE Healthcare Details
2.3.2 GE Healthcare Major Business
2.3.3 GE Healthcare Pharma 4.0 Product and Solutions
2.3.4 GE Healthcare Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 GE Healthcare Recent Developments and Future Plans
2.4 Boston Scientific
2.4.1 Boston Scientific Details
2.4.2 Boston Scientific Major Business
2.4.3 Boston Scientific Pharma 4.0 Product and Solutions
2.4.4 Boston Scientific Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Boston Scientific Recent Developments and Future Plans
2.5 Medtronic Plc.
2.5.1 Medtronic Plc. Details
2.5.2 Medtronic Plc. Major Business
2.5.3 Medtronic Plc. Pharma 4.0 Product and Solutions
2.5.4 Medtronic Plc. Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Medtronic Plc. Recent Developments and Future Plans
2.6 Lonza Group AG
2.6.1 Lonza Group AG Details
2.6.2 Lonza Group AG Major Business
2.6.3 Lonza Group AG Pharma 4.0 Product and Solutions
2.6.4 Lonza Group AG Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Lonza Group AG Recent Developments and Future Plans
2.7 GlaxoSmithKline plc.
2.7.1 GlaxoSmithKline plc. Details
2.7.2 GlaxoSmithKline plc. Major Business
2.7.3 GlaxoSmithKline plc. Pharma 4.0 Product and Solutions
2.7.4 GlaxoSmithKline plc. Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 GlaxoSmithKline plc. Recent Developments and Future Plans
2.8 Koninklijke Philips N.V.
2.8.1 Koninklijke Philips N.V. Details
2.8.2 Koninklijke Philips N.V. Major Business
2.8.3 Koninklijke Philips N.V. Pharma 4.0 Product and Solutions
2.8.4 Koninklijke Philips N.V. Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Koninklijke Philips N.V. Recent Developments and Future Plans
2.9 Glatt GmbH
2.9.1 Glatt GmbH Details
2.9.2 Glatt GmbH Major Business
2.9.3 Glatt GmbH Pharma 4.0 Product and Solutions
2.9.4 Glatt GmbH Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Glatt GmbH Recent Developments and Future Plans
2.10 Vertex
2.10.1 Vertex Details
2.10.2 Vertex Major Business
2.10.3 Vertex Pharma 4.0 Product and Solutions
2.10.4 Vertex Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Vertex Recent Developments and Future Plans
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business
2.11.3 Johnson & Johnson Pharma 4.0 Product and Solutions
2.11.4 Johnson & Johnson Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Johnson & Johnson Recent Developments and Future Plans
2.12 Goodly Innovations
2.12.1 Goodly Innovations Details
2.12.2 Goodly Innovations Major Business
2.12.3 Goodly Innovations Pharma 4.0 Product and Solutions
2.12.4 Goodly Innovations Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Goodly Innovations Recent Developments and Future Plans
2.13 QbDVision
2.13.1 QbDVision Details
2.13.2 QbDVision Major Business
2.13.3 QbDVision Pharma 4.0 Product and Solutions
2.13.4 QbDVision Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 QbDVision Recent Developments and Future Plans
2.14 Electrosan
2.14.1 Electrosan Details
2.14.2 Electrosan Major Business
2.14.3 Electrosan Pharma 4.0 Product and Solutions
2.14.4 Electrosan Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Electrosan Recent Developments and Future Plans
2.15 GoSilico
2.15.1 GoSilico Details
2.15.2 GoSilico Major Business
2.15.3 GoSilico Pharma 4.0 Product and Solutions
2.15.4 GoSilico Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 GoSilico Recent Developments and Future Plans
2.16 Smart Factory
2.16.1 Smart Factory Details
2.16.2 Smart Factory Major Business
2.16.3 Smart Factory Pharma 4.0 Product and Solutions
2.16.4 Smart Factory Pharma 4.0 Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Smart Factory Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharma 4.0 Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Pharma 4.0 Players Market Share in 2021
3.2.2 Top 10 Pharma 4.0 Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Pharma 4.0 Players Head Office, Products and Services Provided
3.4 Pharma 4.0 Mergers & Acquisitions
3.5 Pharma 4.0 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pharma 4.0 Revenue and Market Share by Type (2017-2022)
4.2 Global Pharma 4.0 Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Pharma 4.0 Revenue Market Share by Application (2017-2022)
5.2 Global Pharma 4.0 Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Pharma 4.0 Revenue by Type (2017-2028)
6.2 North America Pharma 4.0 Revenue by Application (2017-2028)
6.3 North America Pharma 4.0 Market Size by Country
6.3.1 North America Pharma 4.0 Revenue by Country (2017-2028)
6.3.2 United States Pharma 4.0 Market Size and Forecast (2017-2028)
6.3.3 Canada Pharma 4.0 Market Size and Forecast (2017-2028)
6.3.4 Mexico Pharma 4.0 Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Pharma 4.0 Revenue by Type (2017-2028)
7.2 Europe Pharma 4.0 Revenue by Application (2017-2028)
7.3 Europe Pharma 4.0 Market Size by Country
7.3.1 Europe Pharma 4.0 Revenue by Country (2017-2028)
7.3.2 Germany Pharma 4.0 Market Size and Forecast (2017-2028)
7.3.3 France Pharma 4.0 Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Pharma 4.0 Market Size and Forecast (2017-2028)
7.3.5 Russia Pharma 4.0 Market Size and Forecast (2017-2028)
7.3.6 Italy Pharma 4.0 Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pharma 4.0 Revenue by Type (2017-2028)
8.2 Asia-Pacific Pharma 4.0 Revenue by Application (2017-2028)
8.3 Asia-Pacific Pharma 4.0 Market Size by Region
8.3.1 Asia-Pacific Pharma 4.0 Revenue by Region (2017-2028)
8.3.2 China Pharma 4.0 Market Size and Forecast (2017-2028)
8.3.3 Japan Pharma 4.0 Market Size and Forecast (2017-2028)
8.3.4 South Korea Pharma 4.0 Market Size and Forecast (2017-2028)
8.3.5 India Pharma 4.0 Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Pharma 4.0 Market Size and Forecast (2017-2028)
8.3.7 Australia Pharma 4.0 Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Pharma 4.0 Revenue by Type (2017-2028)
9.2 South America Pharma 4.0 Revenue by Application (2017-2028)
9.3 South America Pharma 4.0 Market Size by Country
9.3.1 South America Pharma 4.0 Revenue by Country (2017-2028)
9.3.2 Brazil Pharma 4.0 Market Size and Forecast (2017-2028)
9.3.3 Argentina Pharma 4.0 Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pharma 4.0 Revenue by Type (2017-2028)
10.2 Middle East & Africa Pharma 4.0 Revenue by Application (2017-2028)
10.3 Middle East & Africa Pharma 4.0 Market Size by Country
10.3.1 Middle East & Africa Pharma 4.0 Revenue by Country (2017-2028)
10.3.2 Turkey Pharma 4.0 Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Pharma 4.0 Market Size and Forecast (2017-2028)
10.3.4 UAE Pharma 4.0 Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Figures, Tables and Charts Available in Global Pharma 4.0 Market 2022 by Company, Regions, Type and Application, Forecast to 2028
List of TablesTable 1. Global Pharma 4.0 Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Pharma 4.0 Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Pharma 4.0 Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Pharma 4.0 Revenue (USD Million) by Region (2017-2022)
Table 5. Global Pharma 4.0 Revenue Market Share by Region (2023-2028)
Table 6. Pfizer Inc Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Inc Major Business
Table 8. Pfizer Inc Pharma 4.0 Product and Solutions
Table 9. Pfizer Inc Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Pharma 4.0 Product and Solutions
Table 13. Abbott Laboratories Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 15. GE Healthcare Major Business
Table 16. GE Healthcare Pharma 4.0 Product and Solutions
Table 17. GE Healthcare Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Boston Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Boston Scientific Major Business
Table 20. Boston Scientific Pharma 4.0 Product and Solutions
Table 21. Boston Scientific Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Medtronic Plc. Corporate Information, Head Office, and Major Competitors
Table 23. Medtronic Plc. Major Business
Table 24. Medtronic Plc. Pharma 4.0 Product and Solutions
Table 25. Medtronic Plc. Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Lonza Group AG Corporate Information, Head Office, and Major Competitors
Table 27. Lonza Group AG Major Business
Table 28. Lonza Group AG Pharma 4.0 Product and Solutions
Table 29. Lonza Group AG Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. GlaxoSmithKline plc. Corporate Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline plc. Major Business
Table 32. GlaxoSmithKline plc. Pharma 4.0 Product and Solutions
Table 33. GlaxoSmithKline plc. Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Koninklijke Philips N.V. Corporate Information, Head Office, and Major Competitors
Table 35. Koninklijke Philips N.V. Major Business
Table 36. Koninklijke Philips N.V. Pharma 4.0 Product and Solutions
Table 37. Koninklijke Philips N.V. Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Glatt GmbH Corporate Information, Head Office, and Major Competitors
Table 39. Glatt GmbH Major Business
Table 40. Glatt GmbH Pharma 4.0 Product and Solutions
Table 41. Glatt GmbH Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Vertex Corporate Information, Head Office, and Major Competitors
Table 43. Vertex Major Business
Table 44. Vertex Pharma 4.0 Product and Solutions
Table 45. Vertex Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 47. Johnson & Johnson Major Business
Table 48. Johnson & Johnson Pharma 4.0 Product and Solutions
Table 49. Johnson & Johnson Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Goodly Innovations Corporate Information, Head Office, and Major Competitors
Table 51. Goodly Innovations Major Business
Table 52. Goodly Innovations Pharma 4.0 Product and Solutions
Table 53. Goodly Innovations Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. QbDVision Corporate Information, Head Office, and Major Competitors
Table 55. QbDVision Major Business
Table 56. QbDVision Pharma 4.0 Product and Solutions
Table 57. QbDVision Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Electrosan Corporate Information, Head Office, and Major Competitors
Table 59. Electrosan Major Business
Table 60. Electrosan Pharma 4.0 Product and Solutions
Table 61. Electrosan Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. GoSilico Corporate Information, Head Office, and Major Competitors
Table 63. GoSilico Major Business
Table 64. GoSilico Pharma 4.0 Product and Solutions
Table 65. GoSilico Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Smart Factory Corporate Information, Head Office, and Major Competitors
Table 67. Smart Factory Major Business
Table 68. Smart Factory Pharma 4.0 Product and Solutions
Table 69. Smart Factory Pharma 4.0 Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Global Pharma 4.0 Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 71. Global Pharma 4.0 Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 72. Breakdown of Pharma 4.0 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Pharma 4.0 Players Head Office, Products and Services Provided
Table 74. Pharma 4.0 Mergers & Acquisitions in the Past Five Years
Table 75. Pharma 4.0 New Entrants and Expansion Plans
Table 76. Global Pharma 4.0 Revenue (USD Million) by Type (2017-2022)
Table 77. Global Pharma 4.0 Revenue Share by Type (2017-2022)
Table 78. Global Pharma 4.0 Revenue Forecast by Type (2023-2028)
Table 79. Global Pharma 4.0 Revenue by Application (2017-2022)
Table 80. Global Pharma 4.0 Revenue Forecast by Application (2023-2028)
Table 81. North America Pharma 4.0 Revenue by Type (2017-2022) & (USD Million)
Table 82. North America Pharma 4.0 Revenue by Type (2023-2028) & (USD Million)
Table 83. North America Pharma 4.0 Revenue by Application (2017-2022) & (USD Million)
Table 84. North America Pharma 4.0 Revenue by Application (2023-2028) & (USD Million)
Table 85. North America Pharma 4.0 Revenue by Country (2017-2022) & (USD Million)
Table 86. North America Pharma 4.0 Revenue by Country (2023-2028) & (USD Million)
Table 87. Europe Pharma 4.0 Revenue by Type (2017-2022) & (USD Million)
Table 88. Europe Pharma 4.0 Revenue by Type (2023-2028) & (USD Million)
Table 89. Europe Pharma 4.0 Revenue by Application (2017-2022) & (USD Million)
Table 90. Europe Pharma 4.0 Revenue by Application (2023-2028) & (USD Million)
Table 91. Europe Pharma 4.0 Revenue by Country (2017-2022) & (USD Million)
Table 92. Europe Pharma 4.0 Revenue by Country (2023-2028) & (USD Million)
Table 93. Asia-Pacific Pharma 4.0 Revenue by Type (2017-2022) & (USD Million)
Table 94. Asia-Pacific Pharma 4.0 Revenue by Type (2023-2028) & (USD Million)
Table 95. Asia-Pacific Pharma 4.0 Revenue by Application (2017-2022) & (USD Million)
Table 96. Asia-Pacific Pharma 4.0 Revenue by Application (2023-2028) & (USD Million)
Table 97. Asia-Pacific Pharma 4.0 Revenue by Region (2017-2022) & (USD Million)
Table 98. Asia-Pacific Pharma 4.0 Revenue by Region (2023-2028) & (USD Million)
Table 99. South America Pharma 4.0 Revenue by Type (2017-2022) & (USD Million)
Table 100. South America Pharma 4.0 Revenue by Type (2023-2028) & (USD Million)
Table 101. South America Pharma 4.0 Revenue by Application (2017-2022) & (USD Million)
Table 102. South America Pharma 4.0 Revenue by Application (2023-2028) & (USD Million)
Table 103. South America Pharma 4.0 Revenue by Country (2017-2022) & (USD Million)
Table 104. South America Pharma 4.0 Revenue by Country (2023-2028) & (USD Million)
Table 105. Middle East & Africa Pharma 4.0 Revenue by Type (2017-2022) & (USD Million)
Table 106. Middle East & Africa Pharma 4.0 Revenue by Type (2023-2028) & (USD Million)
Table 107. Middle East & Africa Pharma 4.0 Revenue by Application (2017-2022) & (USD Million)
Table 108. Middle East & Africa Pharma 4.0 Revenue by Application (2023-2028) & (USD Million)
Table 109. Middle East & Africa Pharma 4.0 Revenue by Country (2017-2022) & (USD Million)
Table 110. Middle East & Africa Pharma 4.0 Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Pharma 4.0 Picture
Figure 2. Global Pharma 4.0 Revenue Market Share by Type in 2021
Figure 3. Cloud
Figure 4. On-premise
Figure 5. Pharma 4.0 Revenue Market Share by Application in 2021
Figure 6. Pharmaceutical Industry Picture
Figure 7. IoT Industry Picture
Figure 8. Medical Equipment Industry Picture
Figure 9. Others Picture
Figure 10. Global Pharma 4.0 Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Pharma 4.0 Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Pharma 4.0 Revenue Market Share by Region (2017-2028)
Figure 13. Global Pharma 4.0 Revenue Market Share by Region in 2021
Figure 14. North America Pharma 4.0 Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Pharma 4.0 Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Pharma 4.0 Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Pharma 4.0 Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Pharma 4.0 Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Pharma 4.0 Market Drivers
Figure 20. Pharma 4.0 Market Restraints
Figure 21. Pharma 4.0 Market Trends
Figure 22. Pfizer Inc Recent Developments and Future Plans
Figure 23. Abbott Laboratories Recent Developments and Future Plans
Figure 24. GE Healthcare Recent Developments and Future Plans
Figure 25. Boston Scientific Recent Developments and Future Plans
Figure 26. Medtronic Plc. Recent Developments and Future Plans
Figure 27. Lonza Group AG Recent Developments and Future Plans
Figure 28. GlaxoSmithKline plc. Recent Developments and Future Plans
Figure 29. Koninklijke Philips N.V. Recent Developments and Future Plans
Figure 30. Glatt GmbH Recent Developments and Future Plans
Figure 31. Vertex Recent Developments and Future Plans
Figure 32. Johnson & Johnson Recent Developments and Future Plans
Figure 33. Goodly Innovations Recent Developments and Future Plans
Figure 34. QbDVision Recent Developments and Future Plans
Figure 35. Electrosan Recent Developments and Future Plans
Figure 36. GoSilico Recent Developments and Future Plans
Figure 37. Smart Factory Recent Developments and Future Plans
Figure 38. Global Pharma 4.0 Revenue Share by Players in 2021
Figure 39. Pharma 4.0 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Pharma 4.0 Revenue Market Share in 2021
Figure 41. Global Top 10 Players Pharma 4.0 Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Pharma 4.0 Revenue Share by Type in 2021
Figure 44. Global Pharma 4.0 Market Share Forecast by Type (2023-2028)
Figure 45. Global Pharma 4.0 Revenue Share by Application in 2021
Figure 46. Global Pharma 4.0 Market Share Forecast by Application (2023-2028)
Figure 47. North America Pharma 4.0 Sales Market Share by Type (2017-2028)
Figure 48. North America Pharma 4.0 Sales Market Share by Application (2017-2028)
Figure 49. North America Pharma 4.0 Revenue Market Share by Country (2017-2028)
Figure 50. United States Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Pharma 4.0 Sales Market Share by Type (2017-2028)
Figure 54. Europe Pharma 4.0 Sales Market Share by Application (2017-2028)
Figure 55. Europe Pharma 4.0 Revenue Market Share by Country (2017-2028)
Figure 56. Germany Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Pharma 4.0 Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Pharma 4.0 Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Pharma 4.0 Revenue Market Share by Region (2017-2028)
Figure 64. China Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Pharma 4.0 Sales Market Share by Type (2017-2028)
Figure 71. South America Pharma 4.0 Sales Market Share by Application (2017-2028)
Figure 72. South America Pharma 4.0 Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Pharma 4.0 Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Pharma 4.0 Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Pharma 4.0 Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Pharma 4.0 Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
Keyplayers in Global Pharma 4.0 Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Pfizer IncAbbott Laboratories
GE Healthcare
Boston Scientific
Medtronic Plc.
Lonza Group AG
GlaxoSmithKline plc.
Koninklijke Philips N.V.
Glatt GmbH
Vertex
Johnson & Johnson
Goodly Innovations
QbDVision
Electrosan
GoSilico
Smart Factory
Request Sample
Request Discount
